Xeris Biopharma Holdings XERS
NASDAQ XERS
$9.08 -0.17 (-1.84%)
At close: Oct 2, 2026 · 4:00 PM EDT

Xeris Biopharma Holdings (XERS) Price to FCF (2025 - 2026)

Updated

Xeris Biopharma Holdings' (XERS) Price to FCF was 24.29 for Q2 2026, up 17.8% from the prior quarter.

Analysis

Xeris Biopharma Holdings (XERS) Price to FCF (2025 - 2026) Analysis & Trends

For FY2025, Price to FCF at Xeris Biopharma Holdings was 45.58.

  • Five-year quarterly Price to FCF spans a low of 20.62 in Q1 2026 and a high of 127.62 in Q3 2025.
  • Per Business Quant data, the three quarters before Q2 2026 came in at 20.62 (Q1 2026), 45.58 (Q4 2025) and 127.62 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Xeris Biopharma Holdings 1.58 Bn 1.14 Bn 79.59 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 24.29
Mar 31, 2026 20.62
Dec 31, 2025 45.58
Sep 30, 2025 127.62
API Access

Xeris Biopharma Holdings Price to FCF API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-fcf&ticker=XERS&period=max&api_key=YOUR_API_KEY